Literature DB >> 1793026

Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat.

P C Will1, T K Thomas, L Iverson, D Buckman, W Weis, C Wilson, A Srivastava.   

Abstract

Platelet activating factor (PAF) induces neutrophilia and produces a variety of gastrointestinal lesions. The role of PAF as a proinflammatory mediator was examined by measuring the production of PAF and the efficacy of the PAF antagonists WEB 2086 and Ro 24-0238 in acetic acid (HOAc)-induced colitis. PAF levels within the colonic mucosa, as measured by radioimmunoassay, increased from 259 +/- 119 ng/mg in control tissue, to 616 +/- 266 ng/mg in HOAc inflamed tissue. The accumulation of neutrophils within the mucosa was decreased by 53 +/- 10% by pretreatment with 3 mg/kg WEB 2086, and by 43 +/- 11% by 3 mg/kg Ro 24-0238. PAF-induced neutrophilia had no effect on the severity of HOAc-induced colitis, therefore, PAF my be involved in sustaining the chronic inflammation of colitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793026     DOI: 10.1007/bf01993272

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.

Authors:  R Eliakim; F Karmeli; E Razin; D Rachmilewitz
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

2.  Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites.

Authors:  T G Tessner; J T O'Flaherty; R L Wykle
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

3.  Effects of platelet-activating factor on ion transport in isolated rat jejunum.

Authors:  A C Hanglow; J Bienenstock; M H Perdue
Journal:  Am J Physiol       Date:  1989-11

4.  Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.

Authors:  S Jancar; P Braquet; P Sirois
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1989-07       Impact factor: 4.006

5.  Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.

Authors:  J L Wallace; P Braquet; G C Ibbotson; W K MacNaughton; G Cirino
Journal:  J Lipid Mediat       Date:  1989 Jan-Feb

6.  Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor.

Authors:  R W Guthrie; G L Kaplan; F A Mennona; J W Tilley; R W Kierstead; J G Mullin; R A LeMahieu; S Zawoiski; M O'Donnell; H Crowley
Journal:  J Med Chem       Date:  1989-08       Impact factor: 7.446

7.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

  7 in total
  2 in total

1.  Nociceptive neuroendocrine negative feedback control of neurogenic inflammation activated by capsaicin in the rat paw: role of the adrenal medulla.

Authors:  F J Miao; W Janig; J D Levine
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

2.  Pharmacological activity of the second generation leukotriene B4 receptor antagonist, SC-53228: effects on acute colonic inflammation and hepatic function in rodents.

Authors:  D J Fretland; C P Anglin; D Widomski; D A Baron; T Maziasz; P F Smith
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.